Abstract
This review covers recent advances in a variety of dyskinesias. Introduction of new drugs for the treatment of myoclonus and sensory biofeedback therapy for focal dystonia are expanding our concepts of these types of movement disorders. Progress in the treatment of action myoclonus is especially noteworthy and has led to the impli cation of serotonin deficit in the pathophysiology of this syndrome. Knowledge of the biochemical pathology of Huntington’s chorea has outpaced therapy for this disorder, but new forms of therapy have been proposed based on the chemical findings. Basic pharmacologic studies suggest pathophysiologic mechanisms for the syndrome known as tardive dyskinesia, but treatment is still far from ideal for this disorder. Other movement disorders with recent therapeutic advances include essential tremor and hemiballism
This review will cover only those dyskinesias in which new therapies have been advanced in the last few years. Aside from parkinsonism, which will not be discussed here, progress in the treatment of movement disorders has been slow, but steady. New drugs are being tested constantly, and the purpose of this review is to call attention to the ongoing evaluations in this field. Descriptions and etiologies for these dyskinesias are covered elsewhere (Fahn, 1976a) and therefore are not repeated here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Allen, N. and Knopp, W. (1976). Hereditary parkinsonsim-dystonia with sustained control by L-dopa and anticholinergic medica tion. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 201–213. Raven Press, New York.
Barrett, R.E., Yahr, M.D. and Duvoisin, R.C. (1970). Torsion dystonia and spasmodic torticollis: results of treatment with L-dopa. Neurology 20 ,107–113.
Batshaw, M.L. and Haslam, R.H.A. (1970). Multidisciplinary management of dystonia misdiagnosed as hysteria. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 367–373. Raven Press, New York.
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K. and Seitelberger, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington: Clinical, morphological and neurochemical correlations. J. Neuroí. Sci. 20 ,415–455.
Charlton, M.H., (Ed.) (1975), Myoolonie Seizures ,Excerpta Medica, International Congress Series, No. 307, Amsterdam.
Chase, T.N. (1970). Biochemical and pharmacologic studies of dystonia. Neurology 20 ,122–126.
Coleman, M. (1970). Preliminary remarks on the L-dopa therapy of dystonia. Neurology 20 ,114–122.
Cooper, I.S. (1972). Levodopa-induced dystonia. Lancet 2, 1317–1318.
Cooper, I.S. (1976). Twenty-year followup study of the neurosurgical treatment of dystonia musculorum deformans. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds) pp. 423–452. Raven Press, New York.
Courville, C.B. (1953). Contributions to the Study of Cerebral Anoxia. Los Angeles, San Lucas Press.
Crane, G.E. (1972). Pseudoparkinsonism and tardive dyskinesia. Arch. Neurol. 27 ,426–430.
DeLean, J., Richardson, J.C. and Hornykiewicz, O. (1976). Benefi cial effects of serotonin precursors in postanoxic action myoclonus. Neurology 26 ,863–868.
Eldridge, R. and Fahn, S. (Eds.) (1976). Dystonia. Advances in Neurology, Vol. 14, Raven Press, New York.
Fahn, S. (1972a). Differential diagnosis of tremors. Med. Chin. No. Am. 56 ,1363–1375.
Fahn, S. (1972b). Treatment of choreic movements with perphenazine. Bis. Nerv. Syst. 33, 653–658.
Fahn, S. (1974). “On-off” phenomenon with levodopa therapy in parkinsonism: Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology 24 ,431–441.
Fahn, S. (1976a). Medical treatment of movement disorders. In Neurological Reviews 1976. pp. 72–106. American Academy of Neurology, Minneapolis.
Fahn, S. (1976b). Biochemistry of the basal ganglia. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 59–88. Raven Press, New York.
Fahn, S. (in press). Gamma-aminobutyric acid, glycine and other putative amino acid neurotransmitters. In: Handbook of Clinical Neurology.
Fahn, S. and Eldridge, R. (1976). Definition of dystonia and classification of the dystonic states. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 1–5. Raven Press, New York.
Geller, M., Kaplan, B., and Christoff, N. (1976). Treatment of dystonic symptoms with carbamazepine. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 403–410. Raven Press, New York.
Goldberg, M.A. and Dorman, J.D. (1976). Intention myoclonus: Successful treatment with clonazepam. Neurology 26 ,24–26.
Hirose, G., Singer, P., Bass, N.H. (1971). Successful treatment of posthypoxic action myoclonus with carbamazepine. J.A.M.A. 218 ,1432–1433.
Hoehn, M.M. and Cherington, M. (in press). Spinal myoclonus. Neurology ,in press.
Isgreen, W.P., Fahn, S., Barrett, R.E., Snider, S.R. and Chutorian, A.M. (1976). Carbamazepine in torsion dystonia. In: Dysto nia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 411–416. Raven Press, New York.
Johnson, W.G. and Fahn, S. (1974). Treatment of vascular hemichorea and hemiballismus with perphenazine. Trans. Am. Neurol. Assoc. 99 ,22–224.
Johnston, G.A.R. (1976). Physiologic pharmacology of GABA and its antagonists in the vertebrate nervous system. In: GABA in Nervous System Function (Roberts, E., Chase, T.N., and Tower, D.B., Eds) pp. 395–411. Raven Press, New York.
Klawans, H.L. (1973). The pharmacology of tardive dyskinesias. Am. J. Psyohiat. 130 ,82–86.
Korein, J., Brudney, J., Grynbaum, B., Sachs-Frankel, G., Weisinger, M., and Levidow, L. (1976). Sensory feedback therapy of spasmodic torticollis and dystonia: Results in treatment of 55 patients. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 375–402. Raven Press, New York.
Lance, J.W. and Adams, R.D. (1963). The syndrome of intention or action myoclonus as a sequel to hypoxic encephalopathy. Brain 86 ,111–136.
Lhermitte, F., Marteau, R. and Degos, L.-F. (1972). Analyse pharmacologique d’un nouveau cas de myoclonies d’intention et d’action post-anoxiques. Rev. Neurol. Paris 126 ,107–114.
Lhermitte, F., Peterflavi, M., Marteau, R., Gazengel, J. and Serdaru, M. (1971). Analyse pharmacologique d’un cas de myoclonies d’intention et d’action post-anoxiques. Rev. Neurol. Paris. 124 ,23–31.
McGeer, P.L. and McGeer, E.G. (1976). The GABA system and function of the basal ganglia: Huntington’s disease. In: GABA in Nervous System Function. (Roberts, E., Chase, T.N., and Tower, D.B., Eds.) pp. 487–495. Raven Press, New York.
Rajput, A.H. (1973). Levodopa in dystonia musculorum deformans. Lancet 1 ,432.
Shapiro, A.K., Shapiro, E.S., Bruun, R.D., Sweet, R., Wayne, H. and Solomon, G. (1976). Gilles de la Tourette’s syndrome: Summary of clinical experience with 250 patients and suggested nomenclature for tic syndromes. In: Dystonia. Advances in Neurology, Vol. 14. (Eldridge, R. and Fahn, S., Eds.) pp. 277–283. Raven Press, New York.
Shoulson, I., Kartzinel, R., and Chase, T.N. (1976). Huntingtons disease: Treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology 26 ,61–63.
Stahl, W.L. and Swanson, P.D. (1974). Biochemical abnormalities in Huntington’s chorea brains. Neurology 24 ,813–819.
Sweet, R.D., Blumberg, J., Lee, J.E., and McDowell, F.H. (1974). Propranolol treatment of essential tremor. Neurology 24, 64–67.
Tolosa, E.S. and Loewenson, R.B. (1975). Essential tremor: treatment with propranolol. Neurology 25 ,1041–1044.
Urquhart, N., Perry, T.L., Hansen, S. and Kennedy, J. (1975). GABA content and glutamic acid decarboxylase activity in brain of Huntington’s chorea patients and control subjects. J. Neurochem. 24 ,1071–1075.
Van Woert, M.H., Jutkowitz, R., Rosenbaum, P. and Bowers, M.B., Jr. (1976). Serotonin and myoclonus. Monagr. Neural Sci. 3 ,71–80.
Van Woert, M.H. and Sethy, V.H. (1975). Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Neurology 25 ,135–140.
Winkler, G.F. and Young, R.R. (1974). Efficacy of chronic propranolol therapy in action tremors of the familial, senile or essential varieties. N. Engl. J. Med. 290 ,984–988.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1977 Plenum Press, New York
About this chapter
Cite this chapter
Fahn, S. (1977). New Approaches in the Management of Hyperkinetic Movement Disorders. In: Messiha, F.S., Kenny, A.D. (eds) Parkinson’s Disease. Advances in Experimental Medicine and Biology, vol 90. Springer, New York, NY. https://doi.org/10.1007/978-1-4684-2511-6_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-2511-6_7
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4684-2513-0
Online ISBN: 978-1-4684-2511-6
eBook Packages: Springer Book Archive